Evidence map›Paper›PMID 33849545›Full record

ArticleCancer cell international2021

High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients.

Siyi Lu, Zhenzhen Liu, Bingyan Wang, Fei Li, Yan Meng, Junwei Wang, Yuxia Wang, Hao Wang, Xin Zhou, Wei Fu

Abstract read
In one paragraph

Article in Cancer cell international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Analysis of risk characteristics for early progression and late progression in locally advanced rectal cancer patients: a large population-based and validated study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Siyi Lu *Department of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
Zhenzhen Liu *Department of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
Bingyan WangDepartment of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
Fei LiDepartment of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
Yan MengDepartment of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
Junwei WangDepartment of General Surgery, Peking University Third Hospital, Beijing, 100191, China.
Yuxia WangDepartment of Radiotherapy, Peking University Third Hospital, Beijing, 100191, China.
Hao WangDepartment of Radiotherapy, Peking University Third Hospital, Beijing, 100191, China. wanghaobysy@bjmu.edu.cn.
Xin ZhouDepartment of General Surgery, Peking University Third Hospital, Beijing, 100191, China. zhouxinasd@sina.cn.
Wei FuDepartment of General Surgery, Peking University Third Hospital, Beijing, 100191, China. fuwei@bjmu.edu.cn.ORCID http://orcid.org/0000-0001-5248-7891

Funding

National Natural Science Foundation of China 81972702National Natural Science Foundation of China 91959110Natural Science Foundation of Beijing Municipality 7204324
6 · The paper itself

Abstract

backgroundPreoperative tumor markers, inflammation, and nutritional status are considered important predictors of prognosis and tumor response in locally advanced rectal cancer (LARC) patients. This study aims to explore the prognostic and predictive role of carcinoembryonic antigen (CEA), the Fibrinogen-Albumin Ratio Index (FARI), the Prognostic Nutritional Index (PNI) in LARC patients and compared them with a novel combined CEA-FARI-PNI (CFP) scoring system.

methodsA total of 138 LARC patients undergoing radical surgery following neoadjuvant chemoradiotherapy (NCRT) between January 2012 and March 2019 were enrolled. The X-tile program was used to determine the optimal cut-off values of CEA, FARI, and PNI, and CFP scoring system was constructed accordingly. The prognostic ability of these factors was assessed by the time-dependent receiver operating characteristic (ROC) curve, Kaplan-Meier, Cox regression, and logistic regression. Nomogram was established to evaluate the predictive role of these factors in tumor response.

resultsThe optimal cut-off values of CEA, FARI, and PNI were 5.15 ng/l, 10.56%, and 42.25 g/L, respectively. The time-dependent ROC curve showed that compared to CEA, FARI, and PNI, CFP showed stable predictive efficacy for overall survival (OS) and disease-free survival (DFS). In multivariate analysis, CFP was the only factor that could independently predict OS (HR = 8.117, p = 0.001) and DFS (HR = 4.994, p < 0.001). Moreover, high CFP (OR = 3.693, p = 0.002) was also an independent risk factor of poor response. The area under the ROC curve (AUC) of the nomograms for predicting tumor response was better including CFP (0.717) than without CFP (0.656) (p < 0.05).

conclusionsThe CFP score was a more reliable marker for predicting OS, DFS, and NCRT efficacy in LARC patients, and the score could apparently improve predicted efficacy of the nomogram.

Indexed as

CFPPrognosisRectal cancerTumor regression grade

Identifiers

PMID33849545
PMCPMC8045186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.